Functional redundancy between Apc and Apc2 regulates tissue homeostasis and prevents tumorigenesis in murine mammary epithelium. 2017

C S Daly, and P Shaw, and L D Ordonez, and G T Williams, and J Quist, and A Grigoriadis, and J H Van Es, and H Clevers, and A R Clarke, and K R Reed
European Cancer Stem Cell Research Institute, Cardiff University School of Biosciences, Cardiff, Wales, UK.

Aberrant Wnt signaling within breast cancer is associated with poor prognosis, but regulation of this pathway in breast tissue remains poorly understood and the consequences of immediate or long-term dysregulation remain elusive. The exact contribution of the Wnt-regulating proteins adenomatous polyposis coli (APC) and APC2 in the pathogenesis of human breast cancer are ill-defined, but our analysis of publically available array data sets indicates that tumors with concomitant low expression of both proteins occurs more frequently in the 'triple negative' phenotype, which is a subtype of breast cancer with particularly poor prognosis. We have used mouse transgenics to delete Apc and/or Apc2 from mouse mammary epithelium to elucidate the significance of these proteins in mammary homeostasis and delineate their influences on Wnt signaling and tumorigenesis. Loss of either protein alone failed to affect Wnt signaling levels or tissue homeostasis. Strikingly, concomitant loss led to local disruption of β-catenin status, disruption in epithelial integrity, cohesion and polarity, increased cell division and a distinctive form of ductal hyperplasia with 'squamoid' ghost cell nodules in young animals. Upon aging, the development of Wnt activated mammary carcinomas with squamous differentiation was accompanied by a significantly reduced survival. This novel Wnt-driven mammary tumor model highlights the importance of functional redundancies existing between the Apc proteins both in normal homeostasis and in tumorigenesis.

UI MeSH Term Description Entries

Related Publications

C S Daly, and P Shaw, and L D Ordonez, and G T Williams, and J Quist, and A Grigoriadis, and J H Van Es, and H Clevers, and A R Clarke, and K R Reed
August 2019, Nature communications,
C S Daly, and P Shaw, and L D Ordonez, and G T Williams, and J Quist, and A Grigoriadis, and J H Van Es, and H Clevers, and A R Clarke, and K R Reed
February 2009, PLoS genetics,
C S Daly, and P Shaw, and L D Ordonez, and G T Williams, and J Quist, and A Grigoriadis, and J H Van Es, and H Clevers, and A R Clarke, and K R Reed
October 2010, Cancer research,
C S Daly, and P Shaw, and L D Ordonez, and G T Williams, and J Quist, and A Grigoriadis, and J H Van Es, and H Clevers, and A R Clarke, and K R Reed
January 2011, PloS one,
C S Daly, and P Shaw, and L D Ordonez, and G T Williams, and J Quist, and A Grigoriadis, and J H Van Es, and H Clevers, and A R Clarke, and K R Reed
June 2013, Cancer biology & therapy,
C S Daly, and P Shaw, and L D Ordonez, and G T Williams, and J Quist, and A Grigoriadis, and J H Van Es, and H Clevers, and A R Clarke, and K R Reed
November 2018, Blood,
C S Daly, and P Shaw, and L D Ordonez, and G T Williams, and J Quist, and A Grigoriadis, and J H Van Es, and H Clevers, and A R Clarke, and K R Reed
May 2014, The Journal of clinical investigation,
C S Daly, and P Shaw, and L D Ordonez, and G T Williams, and J Quist, and A Grigoriadis, and J H Van Es, and H Clevers, and A R Clarke, and K R Reed
April 1977, Cancer research,
C S Daly, and P Shaw, and L D Ordonez, and G T Williams, and J Quist, and A Grigoriadis, and J H Van Es, and H Clevers, and A R Clarke, and K R Reed
October 2000, Journal of mammary gland biology and neoplasia,
C S Daly, and P Shaw, and L D Ordonez, and G T Williams, and J Quist, and A Grigoriadis, and J H Van Es, and H Clevers, and A R Clarke, and K R Reed
June 2025, iScience,
Copied contents to your clipboard!